Nanomaterial-based Optical and Electrochemical Biosensors for Amyloid beta and Tau: Potential for early diagnosis of Alzheimer's Disease

LMT Phan, TX Hoang, TAT Vo, HL Pham… - Expert Review of …, 2021 - Taylor & Francis
Introduction Alzheimer's disease (AD), a heterogeneous pathological process representing
the most common causes of dementia worldwide, has required early and accurate …

Functional Nanomaterials for the Diagnosis of Alzheimer's Disease: Recent Progress and Future Perspectives

SA Abdullah, L Najm, L Ladouceur… - Advanced Functional …, 2023 - Wiley Online Library
Alzheimer's disease (AD) is one of the main causes of dementia worldwide, whereby
neuronal death or malfunction leads to cognitive impairment in the elderly population. AD is …

Nanomaterials towards biosensing of Alzheimer's disease biomarkers

P Carneiro, S Morais, MC Pereira - Nanomaterials, 2019 - mdpi.com
Alzheimer's disease (AD) is an incurable and highly debilitating condition characterized by
the progressive degeneration and/or death of nerve cells, which leads to manifestation of …

Nanoconstructs as a versatile tool for detection and diagnosis of Alzheimer biomarkers

D Gopalan, A Pandey, AT Alex, G Kalthur… - …, 2021 - iopscience.iop.org
The current review focuses towards the advancements made in the past decade in the field
of nanotechnology for the early Alzheimer's disease (AD) diagnosis. This review includes …

Biosensors on the road to early diagnostic and surveillance of Alzheimer's disease

P Carneiro, S Morais, M do Carmo Pereira - Talanta, 2020 - Elsevier
Alzheimer's disease is a debilitating and largely untreatable condition with subtle onset and
slow progression over an extensive period of time, which culminate in increasing levels of …

Emerging nanotechnology for Alzheimer's disease: From detection to treatment

N Song, S Sun, K Chen, Y Wang, H Wang… - Journal of Controlled …, 2023 - Elsevier
Abstract Alzheimer's disease (AD), one of the most common chronic neurodegenerative
diseases, is characterized by memory impairment, synaptic dysfunction, and character …

The study of Alzheimer's disease biomarkers: Current role and future prospects of nanosensor technology

M Vestergaard, K Kerman, E Tamiya - NanoBiotechnology, 2006 - Springer
Alzheimer's disease (AD) is by far the most common dementing illness of late life and is
increasing with the ever-growing number of older adults, in particular, in developed …

Optical sensor array for the early diagnosis of Alzheimer's disease

F Li, C Stewart, S Yang, F Shi, W Cui, S Zhang… - Frontiers in …, 2022 - frontiersin.org
Alzheimer's disease (AD) is the most common neurodegenerative disorder and has
complicated pathobiology, leading to irreversible memory loss and severe cognitive …

Rapid multiplexed detection of beta-amyloid and total-tau as biomarkers for Alzheimer's disease in cerebrospinal fluid

C Song, P Deng, L Que - Nanomedicine: Nanotechnology, Biology and …, 2018 - Elsevier
This paper reports the multiplexed monitoring of two promising biomarkers, beta-amyloid
(Aβ42) and total tau (T-tau), in both buffer and cerebrospinal fluid (CSF) for Alzheimer's …

Applications of biosensors in Alzheimer's disease diagnosis

LC Brazaca, I Sampaio, V Zucolotto, BC Janegitz - Talanta, 2020 - Elsevier
Alzheimer's disease (AD) is a neurodegenerative disorder characterized by a progressive
and irreversible cognitive decline. Currently, it affects 36 million people and due to …